Differential role of epigenetic modulators in malignant and normal stem cells: a novel tool in preclinical in vitro toxicology and clinical therapy

Author： Snykers Sarah   Vinken Mathieu   Rogiers Vera   Vanhaecke Tamara  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.81, Iss.8, 2007-08, pp. : 533-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Hematopoietic Stem Cells in Gene Therapy: Pre-Clinical and Clinical Issues

By  

Current Gene Therapy, Vol. 8, Iss. 2, 2008-04 ,pp. : 135-146

Bentham Science Publishers

Access to resources Recommend Favorite

Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-03 ,pp. : 777-787

Bentham Science Publishers

Access to resources Recommend Favorite

Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells

By Borovic Suzana   Cipak Ana   Meinitzer Andreas   Kejla Zvonko   Perovic Darko   Waeg Georg   Zarkovic Neven  

Redox Report, Vol. 12, Iss. 1-2, 2007-02 ,pp. : 50-54

Maney Publishing

Access to resources Recommend Favorite

Regenerative toxicology: the role of stem cells in the development of chronic toxicities

By Canovas-Jorda David   Louisse Jochem   Pistollato Francesca   Zagoura Dimitra   Bremer Susanne  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 39-50

Informa Healthcare

Access to resources Recommend Favorite

Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 18, 2012-06 ,pp. : 2644-2656

Bentham Science Publishers

Access to resources Recommend Favorite